N-((2S,3S,4R)-3,4-dihydroxy-1-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadecan-2-yl)-8-(4-fluorophenyl)octanamide

ID: ALA1231634

PubChem CID: 25105144

Max Phase: Preclinical

Molecular Formula: C38H66FNO9

Molecular Weight: 699.94

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCc1ccc(F)cc1

Standard InChI:  InChI=1S/C38H66FNO9/c1-2-3-4-5-6-7-8-9-10-11-14-17-20-31(42)34(44)30(27-48-38-37(47)36(46)35(45)32(26-41)49-38)40-33(43)21-18-15-12-13-16-19-28-22-24-29(39)25-23-28/h22-25,30-32,34-38,41-42,44-47H,2-21,26-27H2,1H3,(H,40,43)/t30-,31+,32+,34-,35-,36-,37+,38-/m0/s1

Standard InChI Key:  FBUHIWMNUBFIJZ-ZORUMLJWSA-N

Molfile:  

     RDKit          2D

 49 50  0  0  0  0  0  0  0  0999 V2000
   -9.3303    0.5741    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6158    0.1616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6158   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9013   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9013    0.5741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1869    0.1616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1869   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4724   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7579   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0434   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3290   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6145   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9000   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1856   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4711   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4711    0.1616    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7566   -1.0759    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0422   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0422    0.1616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7566    0.5741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7566    1.3991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4711    1.8116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1856    1.3991    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4711    2.6366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1856    3.0491    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7566    3.0491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7566    3.8741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0422    2.6366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6723    3.0491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3868    2.6366    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0422    1.8116    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6723   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6723   -1.9009    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3868   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3868    0.1616    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1013   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8157   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5302   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2447   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9591   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6736   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3881   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1026   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8170   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5315   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2460   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9604   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6749   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3894   -0.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  5  2  1  0
  4  3  1  0
  7  4  2  0
  6  5  2  0
  7  6  1  0
  8  7  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 12 11  1  0
 13 12  1  0
 14 13  1  0
 15 14  1  0
 15 16  2  0
 15 17  1  0
 18 17  1  1
 18 19  1  0
 32 18  1  0
 19 20  1  0
 21 20  1  6
 21 22  1  0
 21 31  1  0
 22 23  1  6
 22 24  1  0
 24 25  1  1
 24 26  1  0
 26 27  1  1
 26 28  1  0
 28 29  1  1
 28 31  1  0
 29 30  1  0
 32 33  1  1
 34 32  1  0
 34 35  1  6
 36 34  1  0
 37 36  1  0
 38 37  1  0
 39 38  1  0
 40 39  1  0
 40 41  1  0
 42 41  1  0
 43 42  1  0
 44 43  1  0
 45 44  1  0
 46 45  1  0
 47 46  1  0
 48 47  1  0
 49 48  1  0
M  END

Associated Targets(non-human)

Japanese encephalitis virus (187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 699.94Molecular Weight (Monoisotopic): 699.4722AlogP: 4.82#Rotatable Bonds: 28
Polar Surface Area: 168.94Molecular Species: NEUTRALHBA: 9HBD: 7
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.16CX Basic pKa: CX LogP: 6.39CX LogD: 6.39
Aromatic Rings: 1Heavy Atoms: 49QED Weighted: 0.06Np Likeness Score: 0.84

References

1. Lin KH, Liang JJ, Huang WI, Lin-Chu SY, Su CY, Lee YL, Jan JT, Lin YL, Cheng YS, Wong CH..  (2010)  In vivo protection provided by a synthetic new alpha-galactosyl ceramide analog against bacterial and viral infections in murine models.,  54  (10): [PMID:20660669] [10.1128/aac.00368-10]

Source